“Combined Clinicopathologic and MRI Features Show Potential for Predicting Low MammaPrint Risk Group in Breast Cancer Patients”

https://pubmed.ncbi.nlm.nih.gov/38114364

A combined model of clinicopathologic and MRI features shows potential in predicting the low MammaPrint risk group for certain breast cancer patients, which may support decision-making in clinical settings with limited access to MammaPrint.